Evaluation of the pharmacokinetics of 68Ga-DOTATOC in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy.

Source:http://linkedlifedata.com/resource/pubmed/id/16437218

Download in:

View as

General Info

PMID
16437218